Jeddah, Makkah, Saudi Arabia ICD-PS is the famous Corporate Investor, which was founded in 2001. The venture was found in Asia in Saudi Arabia. The main office of represented Corporate Investor is situated in the Jeddah.
The high activity for fund was in 2018. The fund is generally included in less than 2 deals every year. The common things for fund are deals in the range of 50 - 100 millions dollars.
The current fund was established by Khaled Al-Aboodi.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the ICD-PS, startups are often financed by European Investment Bank (EIB), Emerging Capital Partners (ECP). In the next rounds fund is usually obtained by Public Investment Corporation, China Development Bank, Africa Agriculture and Trade Investment Fund.
Besides, a startup needs to be aged more than 20 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Togo. Among the most successful fund investment fields, there are Commercial, Financial Services. Among the various public portfolio startups of the fund, we may underline Oragroup SA
Related Funds
| Fund Name | Location |
| BaseCamp Ventures | Moorestown, New Jersey, United States |
| Calculus Capital | England, London, United Kingdom |
| Ferguson Ventures | Newport News, United States, Virginia |
| Nanjing Zhongyiren Investment | China, Jiangsu, Nanjing |
| Pharmascience | Canada, Montréal, Quebec |
| Uzushio Enterprise | Japan, Tokyo |
| What If Ventures | Frisco, Texas, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 